-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - ORIGINAL ARTICLE
Evaluation and Overview of the National Electronic Injury
Surveillance System-Cooperative Adverse Drug Event
Surveillance Project (NEISS-CADES)
Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*†
Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…
-
effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-indicators-symposium/research
January 01, 2020 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
February 01, 2014 - These areas include treatments
to achieve long-term remission, the benefits and harms
of step-up versus
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/research-gaps_research.pdf
February 01, 2013 - Methods Research Report - Framework for Determining Research Gaps During Systematic Review: Evaluation
Methods Research Report
Framework for Determining Research Gaps During
Systematic Review: Evaluation
Methods Research Report
Framework for Determining Research Gaps During …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - CER # 23:
Effectiveness of Recombinant Human Growth Hormone (rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings 1st Assessment:
• All conclusions for KQ…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
August 01, 2014 - diabetes,
hypertension), smoking status, 10-year CAD
predicted risk, or history of CAD
1.3 What are the harms … No study addressed harms associated with a false positive
diagnosis.
11
Ta
b
le
D
.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
March 19, 2018 - KQ addressed in this review
were determined during the
protocol and did not include
specific drug harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
February 04, 2014 - observational study evidence may also be initially
graded as “moderate” for certain outcomes such as important harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autism-adolescents_disposition-comments.pdf
August 27, 2012 - Need to highlight main point and to use language less tied to the
jargon of this specific field (e.g. harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
March 31, 2010 - None of
these studies reported on adverse events (harms).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
April 09, 2020 - Coronavirus Infection – Results Work-Related Outcomes – Definition Work-Related Outcomes – Results Harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-disorders-imaging_disposition-comments.pdf
November 01, 2011 - . b) Little
information is presented in previous sections to support the statement
that potential harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - Immediate active treatment has tradeoffs, including the
harms of short- and long-term complications from
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
September 01, 2018 - system’s patient
population is substantial, (2) the evidence base clearly shows that benefits outweigh harms
-
effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research-protocol
December 01, 2020 - Potential comparative harms of intranasal corticosteroids in this population (reduced bone growth and
-
effectivehealthcare-admin.ahrq.gov/products/head-neck-cancer-update/research-protocol
December 01, 2019 - observational study evidence may also be initially graded as “moderate” for certain outcomes such as important harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - AHRQ Comparative Effectiveness Review
Surveillance Program
CER #27:
Oral Diabetes Medications for Adults with Type 2
Diabetes: An Update
Original release date: March 2011
Surveillance Report: December 2013
Key Findings:
• For Key Question 1, conclusions on comparative effectiveness of
oral diabetes agent…